Background: Hypertensive disorders, especially preeclampsia, are the leading reason for
provider-initiated preterm birth. We estimated how universal acetylsalicylic acid (ASA) …

Background Hypertensive disorders of pregnancy, including preeclampsia, are a leading
cause of perinatal morbidity and mortality in the United States, particularly among low …

942 Hypertension April 2020 for preeclampsia prophylaxis before 16 weeks gestation. The
women were deemed high-risk primarily based on clinical risk factors similar to the …

Background Low‐dose aspirin prophylaxis is recommended for women at risk of
preeclampsia. Capturing aspirin prophylaxis within administrative databases can be …

High-quality evidence supports the use of low-dose aspirin (ASA) for the prevention of
preeclampsia (PE) in women identified to be at increased risk of developing the condition. 1 …

Objective To evaluate provider adherence to aspirin prophylaxis prescription guidelines for
patients at risk. Study Design A retrospective chart review was performed at Henry Ford …

Importance Low-dose aspirin (LDA) is one of the few evidence-based interventions for
preventing preeclampsia, which is a leading cause of maternal or fetal morbidity and …

Background Preeclampsia (PE) increases maternal and perinatal morbidity and mortality.
Based on a multitude of data from randomized clinical trials, clinical practice guidelines …

Objective The primary aim of this study was to examine the United States Preventative
Services Task Force (USPSTF) guidelines concordant low-dose aspirin (LDA) counseling …

UK's National Institute for Health and Care Excellence, issued recommendations for daily
low-dose aspirin to reduce the incidence of preeclampsia based on maternal demographics …